Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures
Open Access
- 9 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 27 (3) , 672-678
Abstract
Reduction of bone turnover with bisphosphonate treatment alters bone mineral and matrix properties. Our objective was to investigate the effect of bisphosphonate treatment on bone tissue properties near fragility fracture sites in the proximal femur in postmenopausal women with osteoporosis. The mineral and collagen properties of corticocancellous biopsies from the proximal femur were compared in bisphosphonate‐naive (−BIS, n = 20) and bisphosphonate‐treated (+BIS, n = 20, duration 7 ± 5 years) patients with intertrochanteric (IT) and subtrochanteric (ST) fractures using Fourier transform infrared imaging (FTIRI). The mean values of the FTIRI parameter distributions were similar across groups, but the widths of the parameter distributions tended to be reduced in the +BIS group relative to the −BIS group. Specifically, the widths of the cortical collagen maturity and crystallinity were reduced in the +BIS group relative to those of the −BIS group by 28% (+BIS 0.45 ± 0.18 versus −BIS 0.63 ± 0.28, p = 0.03) and 17% (+BIS 0.087 ± 0.012 versus −BIS 0.104 ± 0.036, p = 0.05), respectively. When the tissue properties were examined as a function of fracture morphology within the +BIS group, the FTIR parameters were generally similar regardless of fracture morphology. However, the cortical mineral:matrix ratio was 8% greater in tissue from patients with atypical ST fractures (n = 6) than that of patients with typical (IT or spiral ST) fractures (n = 14) (Atypical 5.6 ± 0.3 versus Typical 5.2 ± 0.5, p = 0.03). Thus, although the mean values of the FTIR properties were similar in both groups, the tissue in bisphosphonate‐treated patients had a more uniform composition than that of bisphosphonate‐naive patients. The observed reductions in mineral and matrix heterogeneity may diminish tissue‐level toughening mechanisms. © 2012 American Society for Bone and Mineral ResearchKeywords
This publication has 35 references indexed in Scilit:
- Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crestJournal of Orthopaedic Research, 2011
- Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneityBone, 2010
- Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white femalesBone, 2009
- Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility FractureJournal of Bone and Mineral Research, 2009
- Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture riskJournal of Orthopaedic Research, 2009
- Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronateOsteoporosis International, 2008
- Spectroscopic markers of bone quality in alendronate-treated postmenopausal womenOsteoporosis International, 2008
- Three Years of Alendronate Treatment Results in Similar Levels of Vertebral Microdamage as After One Year of TreatmentJournal of Bone and Mineral Research, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004